Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

All human whole-genome sequencing initiatives should be conducted under a formal research protocol, and ought to include the development of a data return and counselling policy that can be ...

Overview of Genomics in Cancer Care MarketThe global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

A New Era for Embryo Screening: Juniper Genomics Debuts with World’s First Whole-Genome and Transcriptome Test ...

India's population is genetically one of the most diverse in the world, yet it remains underrepresented in global datasets.

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

Illumina, Inc. ILMN recently entered into a definitive agreement with Standard BioTools LAB to acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets. The ...